ArticleBMC pulmonary medicine2026
Exploring small airway disease in idiopathic pulmonary fibrosis patients: insights from oscillometry analysis.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease, with small airway dysfunction (SAD) increasingly recognized as part of its pathophysiology. This study evaluated SAD prevalence and its association with gas exchange and cardiovascular risk using oscillometry.
methodsForty-eight IPF patients underwent forced oscillation technique (FOT), impulse oscillometry (IOS), spirometry, plethysmography, and DLCO. Key oscillometry indices (R5, R20, R5-R20, X5, AX, Fres) were analyzed. Associations with DLCO%, GAP index, MRC dyspnea score, and Framingham Risk Score (FRS) were assessed. Multivariable regression adjusted for age, sex, smoking, TLC%, antifibrotic use, and GAP stage.
resultsSAD was highly prevalent, with abnormal AX in all participants, elevated Fres in > 90%, and abnormal R5-R20 in ~ 60%, using both FOT and IOS, confirming consistency across devices. AX and Fres correlated strongly with DLCO% (r = - 0.50, - 0.70; both p < 0.001) and remained independently associated after adjustment. Both also correlated with FRS (p < 0.05), suggesting a link between lung stiffness and cardiovascular risk. No associations were seen with GAP or MRC scores. FOT and IOS showed excellent agreement for oscillometric parameters (r > 0.8), demonstrating strong concordance between the two measurement systems.
conclusionSAD is a common, clinically relevant feature of IPF. AX and Fres may serve as sensitive, non-invasive markers for disease monitoring and cardiovascular risk assessment. Further multicenter, longitudinal studies are needed to validate these findings and establish the role of oscillometry in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.